Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Geroni

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Investigational New Drugs|January 1, 1986
Biochemical and biological activity of the anthracycline analog, 4-demethyl-6-O-methyl-doxorubicinF Zunino, B Barbieri, O Bellini, et al.
British Journal of Cancer|January 1, 1997
Estimation of the haematological toxicity of minor groove alkylators using tests on human cord blood cellsM Ghielmini, G Bosshard, L Capolongo, et al.
International Journal of Cancer|January 21, 1993
Establishment of L1210 leukemia cells resistant to the distamycin-A derivative (FCE 24517): characterization and cross-resistance studiesC Geroni, E Pesenti, G Tagliabue, et al.
European Journal of Cancer (Oxford, England : 1990)|April 23, 2003
Blood glutathione as a surrogate marker of cancer tissue glutathione S-transferase activity in non-small cell lung cancer and squamous cell carcinoma of the head and neckE Ferruzzi, R Franceschini, G Cazzolato, et al.
Farmaco (Societa Chimica Italiana : 1989)|July 2, 1998
Synthesis, cytotoxicity and antitumor activity of some new simplified pyrazole analogs of the antitumor agent CC-1065. Effect of an hydrophobic group on antitumor activityP G Baraldi, B Cacciari, A Guiotto, et al.
European Journal of Cancer (Oxford, England : 1990)|March 12, 2003
Predicting the maximum-tolerated dose of PNU-159548 (4-demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin) in humans using CFU-GM clonogenic assays and prospective validationD Moneta, C Geroni, O Valota, et al.
Cancer Research|August 1, 1987
Chemical and biological characterization of 4'-iodo-4'-deoxydoxorubicinB Barbieri, F C Giuliani, T Bordoni, et al.
Anticancer Research|September 1, 1986
DNA polymerases and DNA topoisomerases as targets for the development of anticancer drugsS Spadari, G Pedrali-Noy, F Focher, et al.
Anti-Cancer Drug Design|June 11, 1999
PNU 157977: a new potent antitumour agent exhibiting low in vivo toxicity in mice injected with L1210 leukaemia cellsP G Baraldi, G Balboni, R Romagnoli, et al.
Journal of Medicinal Chemistry|April 1, 1989
Synthesis, DNA-binding properties, and antitumor activity of novel distamycin derivativesF M Arcamone, F Animati, B Barbieri, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Investigational New Drugs|January 1, 1986
Biochemical and biological activity of the anthracycline analog, 4-demethyl-6-O-methyl-doxorubicinF Zunino, B Barbieri, O Bellini, et al.
British Journal of Cancer|January 1, 1997
Estimation of the haematological toxicity of minor groove alkylators using tests on human cord blood cellsM Ghielmini, G Bosshard, L Capolongo, et al.
International Journal of Cancer|January 21, 1993
Establishment of L1210 leukemia cells resistant to the distamycin-A derivative (FCE 24517): characterization and cross-resistance studiesC Geroni, E Pesenti, G Tagliabue, et al.
European Journal of Cancer (Oxford, England : 1990)|April 23, 2003
Blood glutathione as a surrogate marker of cancer tissue glutathione S-transferase activity in non-small cell lung cancer and squamous cell carcinoma of the head and neckE Ferruzzi, R Franceschini, G Cazzolato, et al.
Farmaco (Societa Chimica Italiana : 1989)|July 2, 1998
Synthesis, cytotoxicity and antitumor activity of some new simplified pyrazole analogs of the antitumor agent CC-1065. Effect of an hydrophobic group on antitumor activityP G Baraldi, B Cacciari, A Guiotto, et al.
European Journal of Cancer (Oxford, England : 1990)|March 12, 2003
Predicting the maximum-tolerated dose of PNU-159548 (4-demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin) in humans using CFU-GM clonogenic assays and prospective validationD Moneta, C Geroni, O Valota, et al.
Cancer Research|August 1, 1987
Chemical and biological characterization of 4'-iodo-4'-deoxydoxorubicinB Barbieri, F C Giuliani, T Bordoni, et al.
Anticancer Research|September 1, 1986
DNA polymerases and DNA topoisomerases as targets for the development of anticancer drugsS Spadari, G Pedrali-Noy, F Focher, et al.
Anti-Cancer Drug Design|June 11, 1999
PNU 157977: a new potent antitumour agent exhibiting low in vivo toxicity in mice injected with L1210 leukaemia cellsP G Baraldi, G Balboni, R Romagnoli, et al.
Journal of Medicinal Chemistry|April 1, 1989
Synthesis, DNA-binding properties, and antitumor activity of novel distamycin derivativesF M Arcamone, F Animati, B Barbieri, et al.
Pageof 5